UnitLevel 3Undergraduate

PHA3021 Drugs in health and disease

Faculty of Science

PHA3021 Drugs in health and disease is a level 3, 6-credit-point, undergraduate unit from the Faculty of Science, offered in 2021 in Semester 1 at Clayton. It has no prerequisites and unlocks 2 units.

Credit points
6
Offered in 2021
Semester 1
Clayton
Assessment
Exam 25%
and 3 other tasks

This is the 2021 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review PHA3021.

Requisites

Before PHA3021

No prerequisites or corequisites besides the enrolment rules below.

Enrolment rules

PREREQUISITE: BMS2031; or two of PHA2022, PHY2011, PHY2021, PHY2032 or PHY2042; or BTH2012 and one of BMS1052 or PHY2011

COREQUISITES: PHA3011

Overview

This unit provides an historical overview of the use of drugs, with an emphasis on the principles underlying the safe and effective current use of drugs for the maintenance of health and the treatment of disease. The importance of evidence-based drug therapy is highlighted with an introduction to statistical and epidemiological concepts. The pharmacological properties of drug classes used to treat specific respiratory, cardiovascular and gastrointestinal disorders are studied, concentrating on the rationale for their use. Pharmacological approaches to the study of existing and novel compounds will be reinforced in laboratory sessions.

Offerings in 2021

Teaching periodCampusMode
First semesterClaytonOn campus

Assessment

  • In-semester theme testsIn class test
    30%
  • Lab reports/workshop exercisesReport
    25%
  • Assignment
    20%
  • Examination (3 hours and 10 minutes)Exam
    25%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Explain the major principles underlying the therapeutic use of drugs, including the relevance and assessment of evidence-based medicine;

  2. 2

    Apply knowledge of the actions of major drug classes to explain their therapeutic applications and potential adverse effects;

  3. 3

    Use knowledge of the mechanisms of drug action to predict effects in intact organisms;

  4. 4

    Demonstrate the ability to execute pharmacological experiments to obtain, analyse and interpret data and present this in a written report;

  5. 5

    Demonstrate the ability to undertake literature based research to source and critically evaluate information relevant to current topics in pharmacology and to effectively communicate ideas in oral, visual or written forms.

Workload and teaching

  • Workshops18 hours
  • Laboratories12 hours
  • Lectures24 hours

Two 1-hour lectures and three hours of laboratory or self-directed learning/ workshop per week

Where it fits

PHA3021 is part of 1 area of study in the 2021 handbook.

Contacts

Unit Coordinators
Dr Jane Bourke
Dr Jennifer Irvine
Chief Examiners
Dr Jane Bourke

Common questions

What are the prerequisites for PHA3021?

PHA3021 has no prerequisites, but enrolment rules apply.

What can I take after PHA3021?

PHA3021 is a prerequisite or corequisite for 2 units, including PHA3032 and PHA3042.

When is PHA3021 offered?

In 2021, PHA3021 runs in Semester 1 at Clayton.

Does PHA3021 have an exam?

Yes. The exam is worth 25% of the final mark, alongside 3 other tasks.

Which majors and minors include PHA3021?

PHA3021 is part of Pharmacology.

More details

Credit points
6
Level
3
Study level
Undergraduate
Faculty
Faculty of Science
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Available